Owlet (OWLT) Operating Leases (2022 - 2023)
Owlet's (OWLT) quarterly Operating Leases came in at $1.2 million in Q4 2023, up 2.5% year-on-year from $1.2 million in Q4 2022, and up 1554.17% on a QoQ basis from $72000.0 in Q3 2023.
Owlet (OWLT) Operating Leases (2022 - 2023) Analysis & Trends
Owlet (OWLT) has 2 years of Operating Leases data on file, last reported at $1.2 million in Q4 2023.
- On a quarterly basis, Operating Leases rose 2.5% year-over-year to $1.2 million in Q4 2023; TTM through Dec 2023 was $1.2 million, a 2.5% increase from a year earlier, with the FY2023 full-year figure at $1.2 million, up 2.5% from the prior year.
- Operating Leases for Q4 2023 stood at $1.2 million, up from $72000.0 in the prior quarter.
- Over the last five years, Operating Leases for OWLT reached as high as $3.4 million in Q1 2022 and fell as low as $72000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Owlet | 147.80 Mn | 106.79 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | 715,000.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 3.44 Mn |